During the past decade, Yokohama Rosai Hospital conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 3 clinical trials were completed, i.e. on average, 75% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 3 clinical trials were completed. i.e. 300% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Yokohama Rosai Hospital" #1 sponsor was "Boston Scientific Corporation" with 2 trials, followed by "Eli Lilly and Company" with 2 trials sponsored, "Chiba University" with 1 trials sponsored, "Daiichi Sankyo Co., Ltd." with 1 trials sponsored and "The PCI Guideline Research Society" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Yokohama Rosai Hospital" #1 collaborator was "Guidant Corporation" with 1 trials as a collaborator, "ICON Clinical Research" with 1 trials as a collaborator and "Incyte Corporation" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Yokohama Rosai Hospital" are "Arrhythmias, Cardiac" (2 trials), "Heart Failure" (2 trials), "Alopecia Areata" (1 trials), "Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis" (1 trials) and "Atrial Fibrillation" (1 trials). Many other conditions were trialed in "Yokohama Rosai Hospital" in a lesser frequency.

Most popular intervention types in "Yokohama Rosai Hospital" are "Drug" (5 trials), "Device" (2 trials), "Other" (2 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Baricitinib" (2 trials), "Placebo" (2 trials), "CRT-D" (1 trials), "Du-176b" (1 trials) and "Glucocorticoids" (1 trials). Other intervention names were less common.

The vast majority of trials in "Yokohama Rosai Hospital" are 9 trials for "All" genders.

Currently, there are NaN active trials in "Yokohama Rosai Hospital". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Yokohama Rosai Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Yokohama Rosai Hospital, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".